Next Article in Journal
Comprehensive Analysis of KCNJ14 Potassium Channel as a Biomarker for Cancer Progression and Development
Previous Article in Journal
Key Genes of Immunity Associated with Pterygium and Primary Sjögren’s Syndrome
Previous Article in Special Issue
H2+CO2 Synergistic Plasma Positioning Carboxyl Defects in g-C3N4 with Engineered Electronic Structure and Active Sites for Efficient Photocatalytic H2 Evolution
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 24
Issue 3
10.3390/ijms24032048
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Insights from a Bibliometrics-Based Analysis of Publishing and Research Trends on Cerium Oxide from 1990 to 2020

by
Charlotte L. Fleming
1,
Jessie Wong
1,
Mojtaba Golzan
2,
Cindy Gunawan
3,* and
Kristine C. McGrath
1,*
1
School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia
2
Vision Science Group, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia
3
Australian Institute for Microbiology and Infection, University of Technology Sydney, Sydney, NSW 2007, Australia
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(3), 2048; https://doi.org/10.3390/ijms24032048
Submission received: 20 December 2022 / Revised: 29 December 2022 / Accepted: 29 December 2022 / Published: 20 January 2023
(This article belongs to the Special Issue Applications of Green Chemistry Principles to Nanoscience and Nanotechnology)
Browse Figures
Versions Notes

Abstract

:
The purpose of this study is to evaluate the literature for research trends on cerium oxide from 1990 to 2020 and identify gaps in knowledge in the emerging application(s) of CeONP. Bibliometric methods were used to identify themes in database searches from PubMed, Scopus and Web of Science Core Collection using SWIFT-Review, VOSviewer and SciMAT software programs. A systematic review was completed on published cerium oxide literature extracted from the Scopus database (n = 17,115), identifying themes relevant to its industrial, environmental and biomedical applications. A total of 172 publications were included in the systematic analysis and categorized into four time periods with research themes identified; “doping additives” (n = 5, 1990–1997), “catalysts” (n = 32, 1998–2005), “reactive oxygen species” (n = 66, 2006–2013) and “pathology” (n = 69, 2014–2020). China and the USA showed the highest number of citations and publications for cerium oxide research from 1990 to 2020. Longitudinal analysis showed CeONP has been extensively used for various applications due to its catalytic properties. In conclusion, this study showed the trend in research in CeONP over the past three decades with advancements in nanoparticle engineering like doping, and more recently surface modification or functionalization to further enhanced its antioxidant abilities. As a result of recent nanoparticle engineering developments, research into CeONP biological effects have highlighted its therapeutic potential for a range of human pathologies such as Alzheimer’s disease. Whilst research over the past three decades show the versatility of cerium oxide in industrial and environmental applications, there are still research opportunities to investigate the potential beneficial effects of CeONP in its application(s) on human health.

1. Introduction

Cerium oxide (CeO2), also referred to as nanoceria, is a well-known rare earth element of moderate abundance, found in the lanthanide group in the periodic table [1]. The unique structural properties of CeO2 allow its electron configuration to alter, such that it can exist in both the trivalent Ce3+ (Ce2O3) reduced state and the stable tetravalent Ce4+ (CeO2) oxidized state [1]. This property enhances oxygen storage and release, resulting in its ability to regenerate based on redox cycling in its immediate environment [2,3,4]. Cerium (Ce) when added to oxygen (O2) in nanoparticle formulation (CeONPs) adopts a cubic crystalline structure, akin to a fluorite type structure, enabling the rapid diffusion of oxygen as a function of the number of oxygen vacancies [1,4].
CeONP can be comprised of different nanostructure size, shape, morphology, and composition and have been shown to have strong antioxidant mimetic properties, reflecting the behaviour of enzymes like superoxide dismutase (SOD), catalase, and peroxidase, targeting and scavenging reactive oxygen species (ROS) and reactive nitrite species (RNS) [5]. In addition to the strong antioxidant property CeONP has, it has also been shown to have anti-inflammatory, antibacterial and anti-cancer activity [6,7,8]. Given the various potential application demonstrated for CeONPs, numerous literatures on the potential of CeONP has been published in recent years.
Bibliometric analysis is a branch of scientific computer-assisted review analysis that integrates mathematical and statistical approaches to evaluate academic literature in a specific field [9,10]. Analysis using bibliometric tools have been applied to evaluate research that have been undertaken in specific fields of science to provide a global perspective on how research changes overtime, how they relate to one another, research contribution from different countries and subsequently highlight trends surfacing from the various publications over time [9,10,11]. Bibliometrics studies have been conducted on both magnetite and titanium dioxide nanoparticles, to identify particular hotspots in research, but also highlight the gaps in knowledge about these nanoparticles [11,12]. To the best of our knowledge, no bibliometric studies have been conducted on cerium oxide over the past three decades. The aim of this study was to conduct a bibliometric analysis on studies on cerium oxide published over thirty years from 1990 to 2020 to identify publication trends, the most productive countries in cerium oxide research and research hotspots over the years. This paper will serve as a reference to aid in current and future development of research on cerium oxide.

2. Results

The results from the three databases using the search terms “cerium oxide OR ceria OR nanoceria OR nano ceria” yielded the highest number of publications regardless of the database used. A large difference in the number of publications returned between the databases was noted, with WoS returning ~238% and ~180% more papers compared to PubMed and Scopus, respectively (Table 1). The search term “cerium oxide OR ceria OR nanoceria OR nano ceria AND pathology” returned the smallest number of publications with ~57% less for WoS, ~87% less for PubMed and ~99% less Scopus.

2.1. Topic Modelling

To identify the focus and applications of CeONPs studies conducted from 1990 to 2020, the search “cerium oxide OR ceria OR nanoceria OR nano ceria” was completed using the PubMed database. The database yielded 129 publications which was imported into SWIFT-Review software. The SWIFT-Review software analysed the articles and segregated them based on keywords, where they were then categorized into topic models and organized in ranking order. The SWIFT-Review software found 100 topic models with an overview of the top 19 topic models shown in Figure 1. Analysis of these top models identified research were mainly focus on the biomedical applications of CeONPs, focusing its oxidative properties and surface modifications (Table 2).

2.2. Bibliometric Analysis

To examine the broad development of literature in the research associated with CeONPs, the search “cerium oxide OR ceria OR nanoceria OR nano ceria” in the years 1990–2020 was implemented in the WoS database, yielding 7862 publications. To create a visualization of the co-occurrence of all keyword terms, the extracted dataset (title, abstract and author keywords) was imported into the VOSviewer Software (www.vosviewer.com), Universiteit Leiden, Leiden, Netherlands, Version 1.6.15). The main characteristics obtained from an analysis of the co-occurrence of keywords included the frequency and proximity of similar words. The keywords were further refined to a minimum of 20 occurrences, yielding 144 keywords, then designated by VOSviewer into 9 main cluster groups (Table 3). Each cluster represents major themes of CeONPs studies between 1990–2020. Important findings within each cluster are established with a lay description (Table 3) and a corresponding visualization map with the clusters coded by colour presented in Figure 2. Cluster 1 (red) refers to the biocompatibility and antioxidant properties of CeONPs in biomedicine. Some of the clusters are closely associated; clusters 2 and 4 (green and yellow, respectively) highlight the different doping additives, as well as changes in the nanostructure to increase efficiency in various applications. Clusters 3 (blue), 5 (purple) and 6 (aqua) all refer to CeONP application in environmental remediation and industrial implementation as biofuels. Cluster 7 (orange) refers to CeONPs as additives to biofuels and as a potential therapy for wound healing. Lastly, clusters 8 (brown) and 9 (pink), mention the oxygen defects (vacancies) on the surface and antioxidant activity of CeONPs. This analysis identified nanoparticle engineering enhancements as well as specific fields of nanoparticle use (i.e., environmental remediation), which are further investigated.

2.3. SciMAT

A longitudinal bibliometric study was performed using the SciMAT software from the Scopus dataset (17,115 publications). From 1990 to 1997, the results show a clear trajectory of research interest on CeO2 with the term “doping additives” emerging as the main theme in this time period (n = 1047). Studies in this time period were focused on enhancing the properties of CeO2 through incorporation of additives (e.g., doping, coating, nanocomposites and hybrid nanostructures) and morphological alterations as indicated by the terms “crystal defects” and “crystal lattice (Figure 3a). The term “catalyst” was highlighted as a main theme in 1998–2005 (n = 2937) associated with the terms “thermostability”, “oxygen transport” and “exhaust gas” suggesting its catalytic role as a potential air pollutant adsorber or a biofuel (Figure 3b). In the period of 2006–2013 (n = 7858 publications), “reactive oxygen species” was identified as the main theme, with terms like “cell survival”, “cell death”, “free radicals”, “catalase” and “glutathione”, indicating the research focused on antioxidant properties on cellular models (Figure 3c). The final period between 2014–2020 (n = 5273 publications) indicated “pathology” as a main theme, with “apoptosis”, “cell proliferation” and “drug effect” identified as associated terms suggesting that research in this period focused on CeONPs and its effects on gene expression and cell proliferation as a biomedicine (Figure 3d).

2.4. Systematic Review of Literature

A refined search on the Scopus database was then completed to provide a systematic analysis of the literature from each theme identified from the SciMAT software. A total of 172 publications, refined by a citation ratio of greater than 6 (peer-acknowledged quality threshold), were included in this study. Figure 4 shows the total publications that met the citation criteria; 5 publications were from 1990 to 1997 (“doping additives”), 32 publications from 1998 to 2005 (“catalyst”), 66 publications from 2006 to 2013 (“reactive oxygen species”), and 69 publications from 2014 to 2020 (“pathology”).

2.4.1. Time Period 1990–1997—“Cerium Oxide and Doping-(Additives)”

SciMAT extracted five publications from this period meeting the citation ratio of above 6, focusing on the combined environmental and industrial applications of CeONPs. To enhance CeONPs ionic conductivity for electrolyte fuel cell efficiency, one study doped the CeONPs with zirconia, samaria and gadolinia which resulted in increased oxygen vacancies (or oxygen defects) on its surface thereby making it more reactive [13]. Samaria and gadolinia-doped CeONPs exhibit high electrical conductivity due to the close ionic radii of Sm3+ Gd3+ to that of Ce4+ [13]. The reduction of ceria electrolyte at the fuel side could be suppressed by doping with a thin film of stabilized zirconia on the ceria surface [13].
While the theme of this time period is “doping-additives” of CeONPs, the remaining studies included in this analysis focused mainly on the morphological enhancements of CeONPs due to the FCR threshold implemented. Two publications focused on using bare CeONPs to eliminate contaminants in automobile gas exhaust [14,15]. Bare CeONPs have less oxygen vacancies thereby increasing nanoparticle stability suitable for interactions between small molecules, e.g., hydrogen, carbon dioxide, oxygen and nitric oxide [14,15]. Another publication in this period focused on the structural properties of CeONPs, finding that morphology and surface characteristics greatly influence the behaviour of the nanoparticles, e.g., lattice structure with increased surface area exposed have more oxygen vacancies with a less compact nanostructure but increased reactivity [16]. The last publication in this time focused on CeONPs as an effective industrial catalyst by increasing the efficient of the WGS reaction, which was achieved at low temperature thereby conserving energy [17]. The research on CeONPs in this period highlight its potential as an environmental/industrial fuel cell and energy converting catalytic alternative to fossil fuel sources, which is a topic further investigated in successive time periods.

2.4.2. Time Period 1998–2005—“Cerium Oxide and Catalyst”

In this time-period, 32 publications met the citation ratio criteria, overlapping themes from the previous period including the environmental/industrial applications with advancements (e.g., additives to CeONPs) in renewable energy and as a potential biomedicine in its pure form.
The environmental/industrial applications of CeONPs in this period, make up most of the publications (n = 23) and extend on the previous period with different additives and structural changes. For example, the nanocomposite structure incorporating nanosized particles into a matrix of standard material thus resulting in improved strength, electrical and thermal properties [18]. Many publications focused on CeONPs as renewable energy sources to replace combustion fuel sources (e.g., natural gas, diesel fuel, biodiesel blends, petroleum and coal) [19]. For example, one study used poly-alkene doped CeONPs in a crystalline form with a porous surface thereby increasing the number of surface and oxygen vacancies to enhance the thermo-catalytic stability in solar cells in replacement organic dyes [20]. Gadolinia-doped CeONPs, as a solid fuel electrolyte, was found to have high stability at reduced oxygen pressures improving fuel cell performance while maintaining textural and mechanical integrity, increasing the electrolyte composition therefore making it a promising recyclable renewable source for turbine power [21,22]. Other studies highlighted the use of copper and nickel loaded CeONPs, doped with lanthanum in a hybrid nanocrystalline structure (i.e., hybrid—combination of doping, loading, surface functionalized or nanocomposite additives) [23]. These hybrid structures were highly dispersed due to the doping and loaded component interactions which enhances their catalytic activity through the increased oxygen vacancies of the added components thereby increasing WGS reaction efficiency [23]. CeONPs have also been used as effective pollutant adsorbers, decontaminating wastewater and sediment following the use of additives such as magnesium oxide/aluminium oxide/titania oxide to generate nanocomposites. Modification of the CeONPs for the removal of heavy metals and organic compounds indicated the redox potential to adsorb the contaminants was increased, suggesting the additives and nanostructure enhanced these properties [24,25,26,27,28]. CeONPs nanocomposites have also been investigated as highly efficient catalysts (e.g., copper, zirconia, nickel, aluminium/CeONPs nanocomposites) for methane oxidation (methane is a potent greenhouse gas in the atmosphere and needs to be broken down by combustion, producing heat and therefore making it a useful fuel source) [24,25,29,30]. These nanocomposite structures are ideal for methane oxidation due to catalytic nature of CeO2, achievable at lower temperatures, hence conserving more energy. Platinum and gold/CeONPs nanocomposites in a crystal lattice fluorite structure showed increased reactivity and reducibility for a more efficient catalyst in the WGS reaction as the temperature can be lowered allowing for enhanced energy to be conserved [31,32,33,34,35]. The morphology of CeONPs has been studied in this period (n = 7) to enhance the properties for a specific purpose, with nano-polyhedral, nano-rods, and nanotubes shown to have increased oxidative properties compared to those of the nanosphere [36]. The crystal plane structure of CeO2 nano-rods was found to have higher oxidation activity compared to crystal lattice structure. As more oxygen vacancies are exposed, the structure becomes more reactive and therefore superior fuel cells and environmental remediators [37,38]. A reoccurring theme for environmental/industrial catalysts in this period highlights the manipulation in manufacturing nanotechnology to increase oxygen vacancies on the surface of the nanostructures which improves the catalytic activity. This is further explored in the following period.
The biomedical applications in this period (n = 2) highlighted CeONPs as potential cancer therapies. One study investigated the cellular uptake of polymer micelle coated CeONPs in human lung fibroblasts in vitro models (ATCC and MRC-9 cell lines). These nanostructures showed increased adsorption, agglomeration, dispersion, and retention time compared to bare CeONPs therefore proving to be a superior cancer therapy [39]. The second demonstrated that bare CeONPs in a crystal lattice structure showed differential effects with 99% protection against radiation-induced cell death in human breast carcinoma epithelial in vitro model (MCF-7 cell line) whilst no protection was conferred for the normal human breast epithelial in vitro model (CRL8798 cell line) [40]. These studies provide a good foundation into the successive periods of CeONPs as a biomedicine, with its potential as a cancer drug delivery agent and in chemotherapy radiation.

2.4.3. Time Period 2006 to 2013—“Cerium Oxide and Reactive Oxygen Species”

A total of 66 publications met the citation criteria in this period, with overlapping themes from the previous period: CeONPs as an effective environmental/industrial renewable resource for fuel cells and its biomedical application as a cancer therapy. The environmental/industrial uses of CeONPs in this period (n = 47) highlight the manufacturing manipulations focused on increasing the amount of oxygen vacancies through nanoparticle engineering in adjusting the additives and morphology of the nanostructures. Two studies focused on the effectiveness of CeONPs as an electrolyte fuel cell, with studies assessing samaria- and carbon-based polymer doped CeONP hybrids to increase oxygen vacancies and induce higher energy conversion rates that subsequently improved efficiency, coinciding with low emissions [41,42]. Studies in this period have again highlighted CeONPs as solid electrolyte fuel cells, however in the lattice fluorite structure. This structure improved ionic conductivity and overall efficiency when doped with lower charged cations like zirconia oxide, aluminium oxide, and palladium oxide due to the increased oxygen vacancies on the surface and the interactions between these components [43,44]. Of particular significance in this period, was the platinum oxide, titania oxide, copper oxide, and particularly gold oxides/CeONPs nanocomposites, extensively investigated for further improved efficiency in the WGS reaction [45,46,47,48,49,50,51,52,53]. Adding heterogenous “- oxide” nanoparticles to the CeONP nanocomposite further enhanced the formation of oxygen vacancies on the surface, which increased the catalytic activity of these nanostructures [45,46,47,48,49,50,51,52,53]. Various research inquiries studied CeONPs nanocomposites (e.g., platinum and zirconia/CeONPs) for automotive exhaust gas remediation. These studies found that the nanowire structures, with increased surface presence of oxygen vacancies, were associated with the highest catalytic activities, as well as recyclability of CeONPs [54,55,56,57,58]. These studies showcased innovations in nanostructure engineering, to increase the surface presence of oxygen vacancies, and in turn, enhances the nanostructures catalytic activities. The presence of oxygen vacancies enable CeONPs to readily scavenge free radicals present in pollutants, such as superoxide (O2−), hydroxide (OH−), hydroxyl (OH) and hydrogen peroxide (H2O2), nitric oxide (NO) and peroxynitrite (ONOO−), thereby beneficial in environmental remediation [59]. This ROS scavenging capability also prompted the biomedical application of CeONPs.
The biomedical research on CeONPs (n = 15) in this period further investigated the potential of CeONPs and exploited the advancements in nanoparticle engineering additives like doping, surface modification and nanocomposites. CeONPs have been found to be protective against ischemic stroke in a cardiac progenitor in vitro model showing no toxicity, in fact increasing cell viability and decreasing apoptosis compared to copper and zinc nanoparticles [60,61,62]. CeONPs have also been used as probes in bioanalysis and diagnostic tests, in the form of a bioactive sensing paper for glucose and H2O2 testing to replace the use of organic dyes, measuring multiple cycles [63]. Studies have shown that CeONPs have antioxidant catalytic properties, having the capacity to mimic superoxide dismutase (SOD), specifically converting superoxide to oxygen and hydrogen peroxide with high specificity and efficiency, highlighting its ability to scavenge ROS and RNS and therefore an effective antioxidant [64,65,66]. The term “doping” consists of the insertion of a new specific ion into a crystal lattice structure, where “coating” consists of a thin film applied to the surface, encapsulating a nanomaterial [67]. Conjugation of CeONPs with polymers (e.g., polyacrylic acid, animated poly(acrylic acid), dextran-coated) were indicated to increase CeO2 oxidase-like activity, as well as enhancing the nanoparticles cell targeting activities, and in turn, their cellular uptake in in vitro models (lung carcinoma—A549, cardiac myocytes—H9c2, embryonic kidney—HEK293 and breast carcinoma—MCF-7 cell lines) [68,69]. Dextran-conjugated CeONPs were found to exhibit protective effects on human dermal fibroblast (HDF) cell line, being correlated to the particle ROS scavenging ability [70]. Another study by Kim and colleagues showed polyethylene glycol (PEG)-conjugated CeONPs protected against ROS-induced cell death in vitro (using ovarian hamster CHO-K1 cells) and subsequently observed protection against ischemic induced-apoptotic cell death in the brain in an in vivo model of ischemic stroke [71]. Similarly, Asati and colleagues investigated yttrium oxide/CeONP nanocomposites on a nerve cell model (HT22 cell line) and observed neuroprotective effects of the nanoparticles, with a lowered oxidative stress and cell toxicity [72]. These studies show the broad range of biomedical applications and disease pathologies, which CeONPs have been implicated for, highlighting the nanotechnology advancements that improve the biocompatibility of the nanostructures (e.g., ROS scavenging ability to reduce oxidative stress, indicated increased circulation time and cellular uptake). These studies have directly influenced the biomedical applications of CeONPs in the following period (2014–2020).
Four publications in this period reported the potential toxicity and hazards that CeONPs and other nanoparticles poses to human health and the environment. Exposing pure CeONPs to a human bronchus epithelial in vitro model (BEAS-2B cell line) induced cell death with decreased intercellular glutathione (GSH) reported [73]. This enzyme is an effective ROS scavenger and playing a key role in the inflammatory and oxidative stress pathways [73]. Another study found that CeONPs induced oxidative damage and led to decreased lifespan in an in vivo model (Caenorhabdotis Elegans cell line) [74]. Similarly, exposure of CeONPs decreased cell viability and increased ROS production in a human skin melanoma in vitro model (A375 cell line) [75]. In acidic conditions the antioxidant ability of CeONPs is lost, behaving instead much like a strong oxidant, which may influence the oxidation of intracellular and extracellular components to induce apoptosis [76]. This ability to become cytotoxic has been found to induce oxidative stress, could be attributed to cancer cells being more acidic than normal cells [70,77]. The bifunctional characteristic of CeONPs allows it to exhibit both ROS scavenging and cytotoxic effects is possible due to its ability to change structural composition in valency depending on the environment [78,79]. These studies provide insight into the various therapeutic applications of CeONPs, which is further examined in the final period of CeO2 research.

2.4.4. Time Period 2014–2020—“Cerium Oxide and Pathology”

This period yielded the highest number of publications (n = 69), with the highest number of publications (n = 22) from a single year (2020). Following on from the previous period, the broad themes are the same, with most publications highlighting the environmental/industrial applications of CeONPs, with several studies focusing on its biomedical uses.
Environmental/industrial applications of CeO2 make up most of the publications in this period (n = 63). Like the previous period, CeONPs were investigated as renewable resources, efficient fuel cells and remediating the environment through implementing hybrid CeONPs complexes. Of particular interest is the advancement of the single atom catalyst, with one study using platinum single atoms on the surface of CeONPs (surface modified/functionalized support) demonstrating higher reactivity, better selectivity and less agglomeration when heated, resulting in a superior compound compared to the platinum/CeONPs nanocomposite complex [80]. The fluorite lattice structure of CeONPs were exploited in this period with studies using various additives (e.g., titania/CeONPs, lanthanum/CeONPs nanocomposites and nickel, zirconia oxide/CeONP nanocomposites surface functionalized with palladium) for methane combustion and removal of organic dye (e.g., Rhodamine-B dye) with enhanced catalytic performance compared to bare CeONPs [81,82,83]. Another study found that CeONPs supported platinum-selenium clusters (as surface modified/functionalized additives) extending the catalytic reaction which unearthed full regeneration, increased dispersibility and stability of the complex for CO oxidation [84]. The use of the core–shell nickel encapsulated between silica oxide/CeONP nanocomposites was useful in reforming biogas, leading to increased nickel dispersion and reductivity compared to nickel-silica or nickel-ceria alone, therefore resulting in the development of a potential sustainable hydrogen fuel source [85]. All these studies extend from the previous periods of CeONPs research further highlighting the versatility of CeONPs, leading to additional advancements in catalytic control and improved performance from an environmentally conscious and industrial perspective.
The remaining publications highlight the biomedical applications of CeONPs, engineering the nanoparticles to enhance their biological activities, as well as, continuingly, the engineering of CeONPs for environmental/industrial applications. Following on from the previous period, montmorillonite loaded CeONP nanocomposites and porphyrin surface modified/functionalized CeONPs have been explored as diagnostic tools to detect hydrogen peroxide (H2O2) and glucose [86,87]. These nanostructures were found to exhibit peroxidase (enzyme that reacts with H2O2 to catalyse oxidation of a number of inorganic compounds in samples) like catalytic activity demonstrating a colorimetric sensitive and specific method, indicating its potential for biochemical assays, clinical diagnosis and environmental monitoring [86,87]. Advancing the idea of CeONP as a therapy in cancer in this time period, one study demonstrated the use of manganese doped-CeONP nanocomposites inducing higher cytotoxicity effects in an adenocarcinoma in vitro model (MCF7 cell line) compared to bare CeONPs [88]. The enhanced cytotoxic effect is likely due to the higher oxygen vacancies generated from adding manganese, producing increased ROS generation which target and kill the cancerous cells, therefore demonstrating its potential as a promising cancer targeting therapy [88]. The bifunctional properties of CeONPs allow it to change its role from antioxidant to pro-oxidant, depending on its surrounding environment, with an acidic environment inducing a pro-oxidant cytotoxic property allowing it to target cancer cells [89]. CeONPs as a drug delivery agent was also investigated for its use in acute kidney injury (AKI) [90]. In this instance, exposure of surface modified/functionalized CeONPs with triphenylphosphine, conjugated with an ROS-responsive organic polymer (PEG—polylactic acid-glycolic acid copolymer), and further loaded with atorvastatin, resulted in protection against tubular cell apoptosis and necrosis in an LPS-induced AKI in vivo model. This study showed the successful modification of CeONPs to target the kidney and selectively release the drug in response to the presence of ROS [90]. Another study highlighted CeONPs as an effective drug delivery agent, using CeONPs encapsulated within zeolithic imidazole framework-8. This nanostructure could penetrate the blood–brain barrier (BBB), accumulate in the brain tissue and reduce oxidative damage and apoptosis of neurons, in an ischemic stroke middle cerebral artery occlusion (MCAO) in vivo mouse model [91]. This study confirms those of Kim and collegues in the previous time period of CeONP potential as a therapy for ischemic stroke. CeO2 as neuroprotective agent has further been investigated, with one study adding triphenyl phosphonium (TPP)-conjugated CeONPs as potent ROS/RNS scavengers due to its recyclable ability, reducing oxidative stress in an in vivo Alzheimer’s disease (AD) mouse model (5XFAD transgenic mice) [92].
The advancements in nanoparticle engineering in this period is clear, with extensive use of doping, nanocomposite, surface functionalized or hybrid (doped and nanocomposite) nanostructures, designed for their specific purpose, considering the morphology, surface texture and additives. The biomedical applications of CeONPs in this period, for their ROS scavenging abilities, as anti-inflammatory therapy, as a diagnostic testing method and of particular interest, the neuroprotective properties for neurological diseases and neurodegeneration.

2.4.5. Author Network and Countries with Most Citations for Cerium Oxide Research

The systematic literature search found a wide range of ground-breaking research into CeONPs over the last 30 years identifying advancements in nanoparticle engineering which has increased the understanding of CeO2 properties whilst uncovering a larger body of scientific work for renewable resources, solid fuel cells, along with its potential as cancer, inflammatory and neuroprotective therapies. To evaluate the authors contributing to CeO2 research, an author network was created from the dataset obtained from the WoS database (7862 publications) using the term “cerium oxide OR ceria OR nanoceria OR nano ceria” in the years 1990–2020 (accessed on the 17 September 2020). The data from this search was imported into the VOSviewer software, where a bibliographic database search was completed for co-authorship using full counting method resulting in a total of 25,580 authors. The authors were further refined by a minimum of 10 documents and 10 citations per author (using as an inclusion criteria for peer-acknowledged quality, h-index) which resulted in 68 authors [93]. The author’s affiliations and number of citations were recorded and the percentage of citations per country was calculated and ordered by most to least citations (Figure 5). The top 11 countries were identified, showing the highest number of citations from China, encompassing a total of 37%, indicating that China has led the world in CeO2 research over the last 30 years. Other countries like USA (26%), Iran and India (8%), Canada (5%), Sweden and Spain (4%), Italy (3%), Czech Republic (3%), Netherlands (1%) and Russia (0.4%) have also contributed to CeO2 research over the past 30 years.

3. Discussion

This systematic literature analysis found that the research on “cerium oxide” has developed over the past three decades from initially focusing on understanding the unique physicochemical properties of cerium oxide, into the extensive environmental and industrial applications, and finally focusing on CeONPs as a biomedicine. The biomedical applications of CeONPs in the more recent time periods have uncovered the advancements in nanoparticle engineering (e.g., dopants, coating, surface functionalization, core–shell structures, nanocomposites, and hybrid structures). CeONPs additives were able to increase the already remarkable biological effects of CeONPs as cancer therapeutics, for therapy in inflammatory disease and as diagnostic tools. Moreover, its unique ability to induce cytotoxic effects to cancerous cells whilst inducing protective effects against cytotoxicity in non-cancerous cells indicates its potential for development as therapy for range of pathologies (Figure 6).
The scientific literature on CeO2 over the past 30 years, presented in the topic modelling found the catalytic applications of CeONPs were prominent in the WGS reaction. However, most of the topics that were identified referred to the potential biomedical applications, highlighting its oxidative, antioxidant, catalytic and anti-cancer properties. Further analysis of the topic models using the VOSviewer software, identified nine clusters, highlighting the various fields and developments of CeONP applications largely focusing on the surface and morphological alterations of the nanostructures across various environmental/industrial and biomedical fields.
The SciMAT software was used for a systematic literature analysis, established themes for each time-period. The first period (1990–1997) focused on the environmental/industrial applications of doped and undoped CeONPs, for the enhancement of solid fuel electrolyte cells found to increase the efficiency of the WGS reaction to replace non-renewable resources (e.g., coal, natural gas, oil and nuclear energy) [94]. Replacing non-renewable resources is a major problem for humanity, however, is necessary to create an environmentally sustainable lifestyle. The WGS reaction is significant for this, reforming hydrocarbons to produce hydrogen as an energy source [94]. Fuels produced from hydrogen can be used as direct replacements for oil and gas as low carbon emitting alternatives, which is more environmentally sustainable [95]. CeONPs have been found to be a more effective catalysts for the WGS reaction compared to noble gases (e.g., platinum and manganese) and transition metals (e.g., copper) due to its oxygen storage capacity, facilitated by the ability of transitioning from the trivalent (Ce3+) to the tetravalent (Ce4+) state [96]. This property is enhanced by doping CeONPs with various metal (e.g., platinum, manganese, nickel, cobalt, zirconia and gold) and non-metal (e.g., silica and selenium) catalysts, achieving a powerful catalytic system with increased surface area exposing more oxygen vacancies, resulting in long-term stability and reproducibility, as well as higher CO conversion activity at lower temperatures [94,97,98,99]. In light of these enhanced properties, doping, another manufactured additive is highly utilized in this period and has been shown to be crucial in influencing and controlling the surface reactivity of CeONPs. The doping of CeONPs in this period, focused on increasing the oxygen vacancies (active sites) overall improving catalytic performance and compatibility. This suggests that increasing oxygen vacancies for improved performance is an alteration that is still investigated currently with various studies using additives like titania, lanthanum, zirconia, palladium, yttrium and zinc CeONP structures which have increased oxygen vacancies as environmental remediators (e.g., degrade crystal violet dye, Rhodamine-B dye and methane combustion) [81,82,83,100].
The environmental/industrial and biomedical application using CeONPs in the second period (1998 to 2005) continued to focus on the manufacturing alterations of CeONPs to further enhance its performance. The environmental/industrial applications of CeONPs highlight the influence that chemical composition has on its catalytic activity regarding the WGS reaction and environmental remediation. As the catalytic performance relies heavily on oxygen vacancies, the crystal plane and nanorod morphologies of CeONPs were found to exhibit the highest catalytic performance compared to crystal lattice, nanocube and nanosphere structures [36,37,38]. The increased oxygen vacancies had significant impact on the electrostatic surface charge of the nanostructures which affect the agglomeration rate and overall stability of the complex [96]. Nanocomposites incorporate nanosized particles into a matrix, which has increased oxygen vacancies compared to single nanoparticle structures, but also has enhanced reducibility due to the interactions that occur between the nanoparticles in the matrix further improving catalytic performance [18]. CeONP nanocomposites combined with copper, nickel, zirconia, aluminium, platinum and gold nanoparticles have been extensively used for the WGS reaction in this period [101]. CeONPs nanocomposites are still investigated currently in renewable energies, with a study highlighting the use of silica oxide/CeONPs nanocomposites in reforming biogas, and a potential sustainable hydrogen fuel source [85].
Consistent with the environmental/industrial applications of CeONPs in this period (1998 to 2005), manipulations of CeONPs size, morphology, and additives were investigated for its biomedical application, particularly as a cancer targeting therapy. CeONPs have been found to have anti-tumour properties, becoming cytotoxic towards cancer cells pro-oxidant producing ROS to target them (i.e., pro-oxidant), whilst having little to no effect to the surrounding healthy cells [89]. This is due to the enzymatic abilities in effectively switching valence states from the Ce3+ (reduced form) to the Ce4+ (oxidised form) donating an electron [79,102]. Nanoparticle studies have found that sharp edged, large nanostructures are less biocompatible, compared to smooth surface smaller nanostructures, as they can inflict mechanical damage on cell membranes and organelles while triggering an immune response [96]. A study using ultrafine bare CeONPs found that the nanoparticles induced cytotoxicity on a breast carcinoma in vitro model (MCF-7 cell line) [40]. Another study showed that tumour cells create an acidic environment, which induces oxidant like behaviour in CeONPs. This study used murine fibrosarcoma tumour cells (WEH164 cell line) which were injected in the flank of a murine in vivo model (BALB/c). The CeONPs (<50 nm) were extremely efficient in targeting and aggregating at tumour site, finding that enhanced permeability and retention plays a crucial role in delivering the CeONPs to tumour cells [103]. These studies provide further evidence for CeONPs as potent ROS scavengers and potential as effective cancer therapies. Of note, doping CeONPs for biomedical applications surfaced in this period, showing clear advantages, in preventing agglomeration and toxicity compared to undoped equivalents [96]. This is consistent with a study that used dextran-coated CeONPs in an osteosarcoma in vitro model (MG-63 cell line), finding that these nanostructures induced increased toxicity compared to bare-CeONPs. This effect was shown to be dose dependent with increasing toxicity as dextran coating concentration increased [104]. Another study using polymer-doped CeONPs in a human lung fibroblasts in vitro model (ATCC and mRC-9 cell lines) demonstrated rapid adsorption, increased retention time and increase dispersion, compared to the bare CeONP equivalent [39]. Doping CeONPs has been found to improve its antioxidant abilities, more effectively scavenging ROS/RNS, enhancing solubility, stability and dispersion of the nanoparticles, which is further investigated in successive time periods [105]. These studies suggest that CeONPs are effective anti-cancer therapies due to their unique ability to differentiate between healthy and cancerous cells with polymer coated CeONPs showing enhanced efficacy in this ability to target the cancerous cells.
The third period (2006 to 2013), saw further developments in the environmental/industrial applications of CeONPs as a heterogenous catalyst (multiple catalysts in a nanocomposite structure). The use of metal oxide/CeONPs nanocomposites as heterogenous catalysts were used having increased oxygen storage for the WGS reaction [106]. This is seen in a study using metal (platinum, titania, gold) oxide/CeONPs nanocomposites to generate a more efficient catalyst, as the hybrid materials incorporated into the crystal lattice structure provide active support and new oxygen vacancies at the metal oxide/CeONPs interface [106,107]. The biomedical applications in this period, provided support for CeONPs as an anti-cancer agent, however, transitioned into targeting inflammatory driven diseases and wound healing, highlighting its antioxidant abilities. CeONPs are effective cancer targeting therapies due to the pro-oxidant properties which they exhibit [70,77]. These mechanisms of CeONPs are highly reliant on the pH of the surrounding environment being more acidic (pH 6) which is attributed to cancer cells being more acidic than normal cells [108,109,110]. In a more alkaline pH (e.g., pH 7–9) the antioxidant abilities of CeONPs are exhibited, inducing strong ROS scavenging properties [76]. This bifunctional property is due to alternating valence states and hence the ability to regenerate oxygen vacancies, which are active sites for redox reactions (ROS/RNS scavenging) to take place [5,96]. This property of CeONPs is important because oxidative stress is considered central to the progression of chronic inflammation and inflammatory diseases [111]. A study used micro RNA 146a (miR146a)/CeONPs nanocomposites to treat colitis on in vivo murine model (C57BL/6), finding that the nanostructure exhibited an anti-inflammatory and antioxidant activities, decreasing inflammatory cytokines; tumour necrosis factor (TNF) and interleukin 6 (IL-6), coinciding with the reduced oxidative stress [112]. Similarly, in vitro models, adipocyte (3T3-L1 cell line) and myoblast (C2C12 cell line) of diabetes mellitus were exposed to selenium/CeONPs nanocomposites, showing a decrease in extracellular ROS production [113]. These studies show that CeONPs nanocomposites can alleviate oxidative stress and inflammation responses. Oxidative stress has been associated with increased bone loss, as well as limiting bone repair, being correlated to low-grade chronic inflammation. Spherical CeONPs exhibited protective effects, by enhancing cell proliferation as well as osteogenic differentiation and mineralization on a human bone-derived mesenchymal stem cell model (hBMSCs cell line). This study showed the positive effects of CeONPs for tissue and bone regeneration under acute or chronic conditions [114]. Taken together, these studies demonstrate the important biological activities of CeONPs as anti-inflammatory and antioxidant agent, demonstrating the nanoparticles potential use in a wide spectrum of inflammatory-associated diseases. The development of CeONPs nanocomposites in this period highlights advancements in nanoparticle engineering.
The most recent period (2014–2020) showed a significant development in environmental/industrial applications of CeONPs in the single atom catalysts for the WGS reaction. Single atom catalysts, have been developed to increase catalytic performance, due to the increased dispersion rate and the active sites encapsulated on the support structure, achieving higher turnover rates compared to larger nanoparticles [94]. One study used a platinum single atom, supported on CeONP catalysts (1.7 nm in diameter), which reported a high number of surface oxygen vacancies. This structure exhibited increased dispersibility, due to the synergistic effects of platinum and CeO2 [115]. Noble metals atomically dispersed on solid oxide supports, have become the superior form of heterogenous catalysis. An example is the palladium doped CeONPs single atom catalysts, which have been found to have increased interactions between the metal-support, a crucial property for maintaining stability [116].
The CeONPs biomedical applications in this period are the most interesting, identifying a clear trajectory of research into CeONPs as therapies for neurological diseases and in particular neurodegenerative diseases. CeONPs have emerged as potential neurodegenerative therapies due to the ease at which these nanoparticles can be manipulated to adjust the size and additives, for passage through the BBB. One study investigated the effects of CeONPs in an anaplastic astrocytoma in vitro model (grade II glioma), displaying selective cytotoxicity targeting astrocytoma cells [117]. PEG coated CeONPs can easily cross the BBB, therefore various studies exploring treatment for ischemic stroke and multiple sclerosis (MS) have emerged [118]. Studies tested these nanoparticles in in vivo murine models of ischemic stroke and MS effectively scavenging ROS/RNS and reducing overall oxidative stress injury [117,118]. Another study used citrate EDTA stabilized CeONPs in an in vitro murine model (SOD1G93A cell line) of amyotrophic lateral sclerosis (ALS), finding that the ROS/RNS scavenging ability assisted in prolonging lifespan after muscle weakness was observed [118]. These studies demonstrate that CeONPs are able to induce both protective and cytotoxic effects efficient against oxidative stress/inflammatory driven diseases as well as cancer [75]. This dual effect of CeONPs to be both protective and selectively cytotoxic is remarkable and is found to rely on the surrounding pH [89]. In acidic conditions the cytotoxic ability of CeONPs is activated whilst the antioxidant ability is lost, behaving instead much like a strong oxidant which influences the oxidation of intracellular and extracellular components to induce apoptosis in the presence of cancerous cells [76]. This ability to become cytotoxic has been found to induce oxidative stress, could be attributed to cancer cells being more acidic than normal cells [70,77]. The bifunctional characteristic of CeONPs allows it to exhibit both ROS scavenging and cytotoxic effects, due to its ability to change structural composition in valency and its interaction with the surrounding environment [78,79,119]. These properties makes it an extremely versatile compound for various biomedical applications, including an efficient drug targeting device, and in oxidative stress diseases like neurodegeneration [79].
CeONPs as a therapy for neurodegeneration and particularly AD has emerged in recent years due to the driving pathological features where oxidative stress and inflammation is now recognized as playing a key role in disease progression [120,121]. Various studies have tested CeONPs in human neuroblastoma in vitro model (SH-SY5Y cell line) treated with amyloid-beta (Aβ) protein (protein that aggregates and forms Aβ senile plaques, a hallmark pathology of AD) [118,122]. Similarly, the use of CeONPs but coated with an anti-amyloidogenic agent, inhibited amyloidogenic activity with no toxicity present in an in vitro human glial model (U87MG cell line) [123]. These studies highlight CeONPs antioxidant, anti-inflammatory and neuroprotective properties, as well as the ability to permeate the BBB, for its development as a promising therapy for neurological and/or neurodegenerative diseases like AD.
The advancements in nanotechnology over the years have led to the extensive applications of CeONPs in the environmental/industrial and biomedical fields. Whilst the use of CeONPs have mostly been beneficial, adverse effects have been reported. For example, increased dosage and sized of CeONPs was associated with varied toxicity levels and apoptosis in human neuroblastoma cells (IMR32 cell line) [124]. Similarly, oxidative stress and cytotoxicity was increased following exposure to CeONPs in human lung adenocarcinoma cells (A549 cell line) [125]. In contrast, CeONPs showed neuro- and cardio-protective effects through suppression of decrease ROS and oxidative stress [71,126]. These studies indicate that whilst CeONPs has great potential for biomedical applications, future research is still necessary to optimize CeONPs as a therapy, particularly focusing on dosage, administration, particle composition, size and shape which have known effects on their interactions with molecular mechanisms of various cells and tissues in biological systems (Figure 7).

4. Materials and Method

4.1. Topic Modelling

The PubMed (https://pubmed.ncbi.nlm.nih.gov/ (accessed on 17 September 2020)) database was used to search the term “cerium oxide OR ceria OR nanoceria OR nano ceria” from 1990 to 2020. The publications extracted (129 publications; included research and review articles) were exported as a PMID list file and imported into the SWIFT (Sciome Workbench for Interactive Computer-Facilitated Text-mining)—Review software (https://www.sciome.com/swift-review/), where the articles were segregated based on keywords, then organized into topic models of cerium oxide research and ranked in order from most to least prevalent topics. To enlarge the search range, other databases were used as a source of bibliographic data. All databases were accessed in September and October 2020.

4.2. Bibliometric Analysis

Bibliographic data (title, abstract, all citations) for the period of 1990–2020 were exported (txt file) from the Web of Science Core Collection (WoS) database (accessed on the 17 September 2020) using the search “cerium oxide or ceria or nanoceria or nano ceria”. The dataset was then imported into the VOSviewer software (www.vosviewer.com). Any duplicates in the search were removed and a bibliometric analysis (yielding 7862 publications), was performed based on co-occurrence of authors keywords in the paper title (9253 keywords) using full counting, which was then further refined to a minimum of 20 occurrences, yielding 144 keywords.

4.3. Longitudinal Study

A bibliographic search was performed to undertake a review of the literature over the past three decades, using the Scopus database (accessed on the 9 October 2020) with the search term “cerium oxide OR ceria OR nanoceria OR nano ceria” from 1990 to 2020. The dataset was exported (authors keywords) and imported into Science Mapping Analysis Software Tool (SciMAT) (https://sci2s.ugr.es/scimat/) software for analysis. Within the data set, identical and similar words were grouped to identify the literature trends and themes. Publications were reviewed in four time periods (1990–1997, 1998–2005, 2006–2013 and 2014–2020) for ease of investigation in a chronological manner, using the workflow presented in Figure 8. Normalization of all the publications was completed using the analysis function, focusing on keywords and specifically authors keywords, with a frequency reduction minimum of 10, a co-occurrence matrix, the edge value reduction of 8, normalization of association strength, simple algorithm centres and core mapping was used. The quality index (h-index) was used, and for the longitudinal analysis, the inclusion index was used on the overlapping map and the Jaccard’s index was used for the evolution map. The important motor-themes (main themes) in each period were identified by their location in the upper right-hand quadrant of the strategic diagram generated by SciMAT software.

4.4. Systematic Review of Literature

Using the four main motor themes generated from the SciMAT software, a systematic review of the peer-reviewed literature was carried out using the Scopus database (accessed on the 9 October 2020). In this search, the four main motor themes identified in SciMAT were included in the time frame of 1990–2020 (e.g., “cerium oxide OR ceria OR nanoceria OR nano ceria AND doping additives AND catalyst AND reactive oxygen species AND pathology, 1990–2020”). The publications were restricted to the relevant time period related to the motor theme. The publications were assessed according to the Field Citation Ratio (FCR) for all time periods. A total of 172 publications were included in this analysis. A FCR value of greater than 6 was included, indicating peer-acknowledged quality for each publication in this review. Reviews, editorials and short communication were excluded from further analysis.

4.5. Author Network

To establish a co-authorship network, the dataset obtained from the WoS database (new format, RIS file), from the search “cerium oxide OR ceria OR nanoceria OR nano ceria” in the years 1990–2020 (accessed on the 9 October 2020) was imported into VOSviewer software. A bibliographic database search, using full counting method, was then completed for co-authorship which resulted in 25,580 authors identified. The authors were further refined by a minimum of 10 documents and 10 citations per author (used as the inclusion criteria for pear-acknowledge quality, h-index) yielding 68 authors. The authors affiliations, number of citations, along with the affiliated countries were recorded and the percentage of citations per country were calculated to determine the frequency of “magnetite’ research around the world. The percentage of citations per country was calculated and ordered by most to least.

5. Conclusions

The research over the last three decades on CeONPs have made progress in environmental and industrial applications as an effective catalyst, for environmental remediation and replacing fossil fuels with renewable resources. The biomedical applications have also increased our understanding of the properties and characteristics of CeONPs, leading to the manipulation and enhancements of CeO2 nanostructures. The unique redox property of CeO2 makes it a potent antioxidant when compared with other ROS modulators, including promising applications in cancer, inflammatory diseases, neurological diseases, and neurodegeneration. The key to CeONPs as a neurological therapy, is its facilitation to cross the BBB, which is easily obtainable due to the advancements in nanotechnological engineering. Further research in both in vitro and in vivo studies need to be undertaken, to fully understand the exact anti-inflammatory mechanism that CeO2 possesses and the synergistic therapeutic effect of oxidative stress reduction. This will aid in developing therapies for various diseases, showing remarkable potential as a biomedicine for inflammatory diseases, but also for neurodegenerative diseases like AD.

Author Contributions

C.L.F. conducted the search, identified the studies, performed the systematic analysis and wrote the first draft of this manuscript. J.W. contributed to the initial interpretation and first draft of this manuscript. K.C.M. conceptualized the study. K.C.M. and C.G. supervised C.L.F., revised and edited the manuscript, and M.G. provided further edits to the manuscripts. All authors contributed to interpretation and revision of the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

Project funded by the Australian Government Research Training Program Scholarship as part of author Charlotte Fleming’s doctoral degree.

Data Availability Statement

Not applicable.

Acknowledgments

The authors would like to acknowledge the use of BioRender for the creation of the schematics used in Figure 5, Figure 6 and Figure 7.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Dahle, J.T.; Arai, Y. Environmental geochemistry of cerium: Applications and toxicology of cerium oxide nanoparticles. Int. J. Environ. Res. Public Health 2015, 12, 1253–1278. [Google Scholar] [CrossRef]
  2. Karakoti, A.S.; Kuchibhatla, S.V.N.T.; Babu, K.S.; Seal, S. Direct Synthesis of Nanoceria in Aqueous Polyhydroxyl Solutions. J. Phys. Chem. C 2007, 111, 17232–17240. [Google Scholar] [CrossRef]
  3. Murray, E.P.; Tsai, T.; Barnett, S.A. A direct-methane fuel cell with a ceria-based anode. Nature 1999, 400, 649. [Google Scholar] [CrossRef]
  4. Xu, C.; Qu, X. Cerium oxide nanoparticle: A remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Mater. 2014, 6, e90. [Google Scholar] [CrossRef] [Green Version]
  5. Dhall, A.; Self, W. Cerium Oxide Nanoparticles: A Brief Review of Their Synthesis Methods and Biomedical Applications. Antioxidants 2018, 7, 97. [Google Scholar] [CrossRef] [Green Version]
  6. Pourkhalili, N.; Hosseini, A.; Nili-Ahmadabadi, A.; Hassani, S.; Pakzad, M.; Baeeri, M.; Mohammadirad, A.; Abdollahi, M. Biochemical and cellular evidence of the benefit of a combination of cerium oxide nanoparticles and selenium to diabetic rats. World J. Diabetes 2011, 2, 204–210. [Google Scholar] [CrossRef]
  7. Pešić, M.; Podolski-Renić, A.; Stojković, S.; Matović, B.; Zmejkoski, D.; Kojić, V.; Bogdanović, G.; Pavićević, A.; Mojović, M.; Savić, A.; et al. Anti-cancer effects of cerium oxide nanoparticles and its intracellular redox activity. Chem. Biol. Interact. 2015, 232, 85–93. [Google Scholar] [CrossRef]
  8. Nelson, B.C.; Johnson, M.E.; Walker, M.L.; Riley, K.R.; Sims, C.M. Antioxidant Cerium Oxide Nanoparticles in Biology and Medicine. Antioxidants 2016, 5, 15. [Google Scholar] [CrossRef] [Green Version]
  9. Han, J.; Kang, H.-J.; Kim, M.; Kwon, G.H. Mapping the intellectual structure of research on surgery with mixed reality: Bibliometric network analysis (2000–2019). J. Biomed. Inform. 2020, 109, 103516. [Google Scholar] [CrossRef]
  10. Shen, Z.; Wu, H.; Chen, Z.; Hu, J.; Pan, J.; Kong, J.; Lin, T. The Global Research of Artificial Intelligence on Prostate Cancer: A 22-Year Bibliometric Analysis. Front. Oncol. 2022, 12, 513. [Google Scholar] [CrossRef]
  11. Nugraha, A.S. Bibliometric Analysis of Magnetite Nanoparticle Production Research During 2017–2021 Using Vosviewer. Indones. J. Multidiciplinary Res. 2021, 2, 6. [Google Scholar] [CrossRef]
  12. Li, Z.; Hu, M.; Song, H.; Lin, D.; Wang, Y. Toxic effects of nano-TiO(2) in bivalves-A synthesis of meta-analysis and bibliometric analysis. J. Environ. Sci. 2021, 104, 188–203. [Google Scholar] [CrossRef] [PubMed]
  13. Eguchi, K.; Setoguchi, T.; Inoue, T.; Arai, H. Electrical properties of ceria-based oxides and their application to solid oxide fuel cells. Solid State Ion. 1992, 52, 165–172. [Google Scholar] [CrossRef]
  14. Trovarelli, A. Catalytic Properties of Ceria and CeO2-Containing Materials. Catal. Rev. 1996, 38, 439–520. [Google Scholar] [CrossRef]
  15. Sayle, T.X.T.; Parker, S.C.; Catlow, C.R.A. The role of oxygen vacancies on ceria surfaces in the oxidation of carbon monoxide. Surf. Sci. 1994, 316, 329–336. [Google Scholar] [CrossRef]
  16. Yashima, M.; Arashi, H.; Kakihana, M.; Yoshimura, M. Raman Scattering Study of Cubic–Tetragonal Phase Transition in Zr1−xCexO2 Solid Solution. J. Am. Ceram. Soc. 1994, 77, 1067–1071. [Google Scholar] [CrossRef]
  17. Conesa, J. Computer modeling of surfaces and defects on cerium dioxide. Surf. Sci. 1995, 339, 337–352. [Google Scholar] [CrossRef]
  18. Malhotra, B.D.; Ali, M.A. Chapter 5—Nanocomposite Materials: Biomolecular Devices. In Nanomaterials for Biosensors; Malhotra, B.D., Ali, M.A., Eds.; William Andrew Publishing: New York, NY, USA, 2018; pp. 145–159. [Google Scholar]
  19. El Morabet, R. Effects of Outdoor Air Pollution on Human Health. In Encyclopedia of Environmental Health, 2nd ed.; Nriagu, J., Ed.; Elsevier: Oxford, UK, 2019; pp. 278–286. [Google Scholar]
  20. Corma, A.; Atienzar, P.; García, H.; Chane-Ching, J.Y. Hierarchically mesostructured doped CeO2 with potential for solar-cell use. Nat. Mater. 2004, 3, 394–397. [Google Scholar] [CrossRef]
  21. Kharton, V.V.; Figueiredo, F.M.; Navarro, L.; Naumovich, E.N.; Kovalevsky, A.V.; Yaremchenko, A.A.; Viskup, A.P.; Carneiro, A.; Marques, F.M.B.; Frade, J.R. Ceria-based materials for solid oxide fuel cells. J. Mater. Sci. 2001, 36, 1105–1117. [Google Scholar] [CrossRef]
  22. Steele, B.C.H. Appraisal of Ce1−yGdyO2−y/2 electrolytes for IT-SOFC operation at 500 °C. Solid State Ion. 2000, 129, 95–110. [Google Scholar] [CrossRef]
  23. Li, Y.; Fu, Q.; Flytzani-Stephanopoulos, M. Low-temperature water-gas shift reaction over Cu- and Ni-loaded cerium oxide catalysts. Appl. Catal. B Environ. 2000, 27, 179–191. [Google Scholar] [CrossRef] [Green Version]
  24. Hori, C.E.; Permana, H.; Ng, K.Y.S.; Brenner, A.; More, K.; Rahmoeller, K.M.; Belton, D. Thermal stability of oxygen storage properties in a mixed CeO2-ZrO2 system. Appl. Catal. B Environ. 1998, 16, 105–117. [Google Scholar] [CrossRef]
  25. Zaki, M.I.; Hasan, M.A.; Al-Sagheer, F.A.; Pasupulety, L. In situ FTIR spectra of pyridine adsorbed on SiO2–Al2O3, TiO2, ZrO2 and CeO2: General considerations for the identification of acid sites on surfaces of finely divided metal oxides. Colloids Surf. A Physicochem. Eng. Asp. 2001, 190, 261–274. [Google Scholar] [CrossRef]
  26. Trovarelli, A.; de Leitenburg, C.; Boaro, M.; Dolcetti, G. The utilization of ceria in industrial catalysis. Catal. Today 1999, 50, 353–367. [Google Scholar] [CrossRef]
  27. Tuller, H.L. Ionic conduction in nanocrystalline materials. Solid State Ion. 2000, 131, 143–157. [Google Scholar] [CrossRef] [Green Version]
  28. Abad, A.; Concepción, P.; Corma, A.; García, H. A collaborative effect between gold and a support induces the selective oxidation of alcohols. Angew. Chem. Int. Ed. 2005, 44, 4066–4069. [Google Scholar] [CrossRef]
  29. Kundakovic, L.; Flytzani-Stephanopoulos, M. Reduction characteristics of copper oxide in cerium and zirconium oxide systems. Appl. Catal. A Gen. 1998, 171, 13–29. [Google Scholar] [CrossRef] [Green Version]
  30. Wang, S.; Lu, G.Q. Role of CeO2 in Ni/CeO2–Al2O3 catalysts for carbon dioxide reforming of methane. Appl. Catal. B Environ. 1998, 19, 267–277. [Google Scholar] [CrossRef]
  31. Hilaire, S.; Wang, X.; Luo, T.; Gorte, R.J.; Wagner, J. A comparative study of water-gas-shift reaction over ceria supported metallic catalysts. Appl. Catal. A Gen. 2001, 215, 271–278. [Google Scholar] [CrossRef]
  32. Fu, Q.; Weber, A.; Flytzani-Stephanopoulos, M. Nanostructured Au–CeO2 Catalysts for Low-Temperature Water–Gas Shift. Catal. Lett. 2001, 77, 87–95. [Google Scholar] [CrossRef]
  33. Rosenzweig, A.C. Biochemistry: Breaking methane. Nature 2015, 518, 309–310. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Ta, N.; Liu, J.; Chenna, S.; Crozier, P.A.; Li, Y.; Chen, A.; Shen, W. Stabilized Gold Nanoparticles on Ceria Nanorods by Strong Interfacial Anchoring. J. Am. Chem. Soc. 2012, 134, 20585–20588. [Google Scholar] [CrossRef] [PubMed]
  35. Han, Z.-K.; Zhang, L.; Liu, M.; Ganduglia-Pirovano, M.V.; Gao, Y. The Structure of Oxygen Vacancies in the Near-Surface of Reduced CeO2 (111) Under Strain. Front. Chem. 2019, 7, 436. [Google Scholar] [CrossRef] [PubMed]
  36. Mai, H.X.; Sun, L.D.; Zhang, Y.W.; Si, R.; Feng, W.; Zhang, H.P.; Liu, H.C.; Yan, C.H. Shape-selective synthesis and oxygen storage behavior of ceria nanopolyhedra, nanorods, and nanocubes. J. Phys. Chem. B 2005, 109, 24380–24385. [Google Scholar] [CrossRef] [PubMed]
  37. Skorodumova, N.V.; Simak, S.I.; Lundqvist, B.I.; Abrikosov, I.A.; Johansson, B. Quantum origin of the oxygen storage capability of ceria. Phys. Rev. Lett. 2002, 89, 166601. [Google Scholar] [CrossRef]
  38. Zhou, K.; Wang, X.; Sun, X.; Peng, Q.; Li, Y. Enhanced catalytic activity of ceria nanorods from well-defined reactive crystal planes. J. Catal. 2005, 229, 206–212. [Google Scholar] [CrossRef]
  39. Limbach, L.K.; Li, Y.; Grass, R.N.; Brunner, T.J.; Hintermann, M.A.; Muller, M.; Gunther, D.; Stark, W.J. Oxide nanoparticle uptake in human lung fibroblasts: Effects of particle size, agglomeration, and diffusion at low concentrations. Environ. Sci. Technol. 2005, 39, 9370–9376. [Google Scholar] [CrossRef]
  40. Tarnuzzer, R.W.; Colon, J.; Patil, S.; Seal, S. Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett. 2005, 5, 2573–2577. [Google Scholar] [CrossRef]
  41. Chen, D.; Ran, R.; Zhang, K.; Wang, J.; Shao, Z. Intermediate-temperature electrochemical performance of a polycrystalline PrBaCo2O5+δ cathode on samarium-doped ceria electrolyte. J. Power Sources 2009, 188, 96–105. [Google Scholar] [CrossRef]
  42. Sharma, S.; Pollet, B.G. Support materials for PEMFC and DMFC electrocatalysts—A review. J. Power Sources 2012, 208, 96–119. [Google Scholar] [CrossRef]
  43. Andersson, D.A.; Simak, S.I.; Skorodumova, N.V.; Abrikosov, I.A.; Johansson, B. Optimization of ionic conductivity in doped ceria. Proc. Natl. Acad. Sci. USA 2006, 103, 3518–3521. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Chuayboon, S.; Abanades, S.; Rodat, S. Syngas production via solar-driven chemical looping methane reforming from redox cycling of ceria porous foam in a volumetric solar reactor. Chem. Eng. J. 2019, 356, 756–770. [Google Scholar] [CrossRef]
  45. Bruix, A.; Rodriguez, J.A.; Ramírez, P.J.; Senanayake, S.D.; Evans, J.; Park, J.B.; Stacchiola, D.; Liu, P.; Hrbek, J.; Illas, F. A new type of strong metal-support interaction and the production of H2 through the transformation of water on Pt/CeO2(111) and Pt/CeO(x)/TiO2(110) catalysts. J. Am. Chem. Soc. 2012, 134, 8968–8974. [Google Scholar] [CrossRef]
  46. Ratnasamy, C.; Wagner, J.P. Water Gas Shift Catalysis. Catal. Rev. 2009, 51, 325–440. [Google Scholar] [CrossRef]
  47. Farmer, J.A.; Campbell, C.T. Ceria Maintains Smaller Metal Catalyst Particles by Strong Metal-Support Bonding. Science 2010, 329, 933. [Google Scholar] [CrossRef] [PubMed]
  48. Wang, X.; Rodriguez, J.A.; Hanson, J.C.; Gamarra, D.; Martínez-Arias, A.; Fernández-García, M. In Situ Studies of the Active Sites for the Water Gas Shift Reaction over Cu−CeO2 Catalysts:  Complex Interaction between Metallic Copper and Oxygen Vacancies of Ceria. J. Phys. Chem. B 2006, 110, 428–434. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  49. Sharma, S.; Hu, Z.; Zhang, P.; McFarland, E.W.; Metiu, H. CO2 methanation on Ru-doped ceria. J. Catal. 2011, 278, 297–309. [Google Scholar] [CrossRef]
  50. Wu, Z.; Jin, R.; Wang, H.; Liu, Y. Effect of ceria doping on SO2 resistance of Mn/TiO2 for selective catalytic reduction of NO with NH3 at low temperature. Catal. Commun. 2009, 10, 935–939. [Google Scholar] [CrossRef]
  51. Roy, T.; Sahani, S.; Chandra Sharma, Y. Study on kinetics-thermodynamics and environmental parameter of biodiesel production from waste cooking oil and castor oil using potassium modified ceria oxide catalyst. J. Clean. Prod. 2020, 247, 119166. [Google Scholar] [CrossRef]
  52. Shapovalov, V.; Metiu, H. Catalysis by doped oxides: CO oxidation by AuxCe1−xO2. J. Catal. 2007, 245, 205–214. [Google Scholar] [CrossRef]
  53. Camellone, M.F.; Fabris, S. Reaction Mechanisms for the CO Oxidation on Au/CeO2 Catalysts: Activity of Substitutional Au3+/Au+ Cations and Deactivation of Supported Au+ Adatoms. J. Am. Chem. Soc. 2009, 131, 10473–10483. [Google Scholar] [CrossRef] [PubMed]
  54. Aneggi, E.; Boaro, M.; de Leitenburg, C.; Dolcetti, G.; Trovarelli, A. Insights into the redox properties of ceria-based oxides and their implications in catalysis. J. Alloy. Compd. 2006, 408, 1096–1102. [Google Scholar] [CrossRef]
  55. Vivier, L.; Duprez, D. Ceria-based solid catalysts for organic chemistry. ChemSusChem 2010, 3, 654–678. [Google Scholar] [CrossRef] [PubMed]
  56. Tana; Zhang, M.; Li, J.; Li, H.; Li, Y.; Shen, W. Morphology-dependent redox and catalytic properties of CeO2 nanostructures: Nanowires, nanorods and nanoparticles. Catal. Today 2009, 148, 179–183. [Google Scholar] [CrossRef]
  57. Gorte, R.J. Ceria in catalysis: From automotive applications to the water–gas shift reaction. AIChE J. 2010, 56, 1126–1135. [Google Scholar] [CrossRef]
  58. Zhong, L.-S.; Hu, J.-S.; Cao, A.-M.; Liu, Q.; Song, W.-G.; Wan, L.-J. 3D Flowerlike Ceria Micro/Nanocomposite Structure and Its Application for Water Treatment and CO Removal. Chem. Mater. 2007, 19, 1648–1655. [Google Scholar] [CrossRef]
  59. Harris, M.E.; Hensley, K.; Butterfield, D.A.; Leedle, R.A.; Carney, J.M. Direct evidence of oxidative injury produced by the Alzheimer’s β-Amyloid peptide (1–40) in cultured hippocampal neurons. Exp. Neurol. 1995, 131, 193–202. [Google Scholar] [CrossRef]
  60. Lanone, S.; Rogerieux, F.; Geys, J.; Dupont, A.; Maillot-Marechal, E.; Boczkowski, J.; Lacroix, G.; Hoet, P. Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines. Part. Fibre Toxicol. 2009, 6, 14. [Google Scholar] [CrossRef]
  61. Lykaki, M.; Pachatouridou, E.; Carabineiro, S.A.C.; Iliopoulou, E.; Andriopoulou, C.; Kallithrakas-Kontos, N.; Boghosian, S.; Konsolakis, M. Ceria nanoparticles shape effects on the structural defects and surface chemistry: Implications in CO oxidation by Cu/CeO2 catalysts. Appl. Catal. B Environ. 2018, 230, 18–28. [Google Scholar] [CrossRef]
  62. Pagliari, F.; Mandoli, C.; Forte, G.; Magnani, E.; Pagliari, S.; Nardone, G.; Licoccia, S.; Minieri, M.; Di Nardo, P.; Traversa, E. Cerium Oxide Nanoparticles Protect Cardiac Progenitor Cells from Oxidative Stress. ACS Nano 2012, 6, 3767–3775. [Google Scholar] [CrossRef]
  63. Ornatska, M.; Sharpe, E.; Andreescu, D.; Andreescu, S. Paper Bioassay Based on Ceria Nanoparticles as Colorimetric Probes. Anal. Chem. 2011, 83, 4273–4280. [Google Scholar] [CrossRef] [PubMed]
  64. Das, M.; Patil, S.; Bhargava, N.; Kang, J.-F.; Riedel, L.M.; Seal, S.; Hickman, J.J. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 2007, 28, 1918–1925. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Korsvik, C.; Patil, S.; Seal, S.; Self, W.T. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem. Commun. 2007, 10, 1056–1058. [Google Scholar] [CrossRef] [PubMed]
  66. Mahmoudi, M.; Sant, S.; Wang, B.; Laurent, S.; Sen, T. Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy. Adv. Drug Deliv. Rev. 2011, 63, 24–46. [Google Scholar] [CrossRef] [Green Version]
  67. Carofiglio, M.; Barui, S.; Cauda, V.; Laurenti, M. Doped Zinc Oxide Nanoparticles: Synthesis, Characterization and Potential Use in Nanomedicine. Appl. Sci. 2020, 10, 5194. [Google Scholar] [CrossRef]
  68. Asati, A.; Santra, S.; Kaittanis, C.; Perez, J.M. Surface-Charge-Dependent Cell Localization and Cytotoxicity of Cerium Oxide Nanoparticles. ACS Nano 2010, 4, 5321–5331. [Google Scholar] [CrossRef] [Green Version]
  69. Asati, A.; Santra, S.; Kaittanis, C.; Nath, S.; Perez, J.M. Oxidase-like activity of polymer-coated cerium oxide nanoparticles. Angew. Chem. 2009, 121, 2344–2348. [Google Scholar] [CrossRef]
  70. Perez, J.M.; Asati, A.; Nath, S.; Kaittanis, C. Synthesis of biocompatible dextran-coated nanoceria with pH-dependent antioxidant properties. Small 2008, 4, 552–556. [Google Scholar] [CrossRef]
  71. Kim, C.K.; Kim, T.; Choi, I.-Y.; Soh, M.; Kim, D.; Kim, Y.-J.; Jang, H.; Yang, H.-S.; Kim, J.Y.; Park, H.-K.; et al. Ceria Nanoparticles that can Protect against Ischemic Stroke. Angew. Chem. Int. Ed. 2012, 51, 11039–11043. [Google Scholar] [CrossRef]
  72. Schubert, D.; Dargusch, R.; Raitano, J.; Chan, S.W. Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem. Biophys. Res. Commun. 2006, 342, 86–91. [Google Scholar] [CrossRef]
  73. Park, E.-J.; Choi, J.; Park, Y.-K.; Park, K. Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology 2008, 245, 90–100. [Google Scholar] [CrossRef] [PubMed]
  74. Zhang, P.; Ma, Y.; Zhang, Z.; He, X.; Zhang, J.; Guo, Z.; Tai, R.; Zhao, Y.; Chai, Z. Biotransformation of Ceria Nanoparticles in Cucumber Plants. ACS Nano 2012, 6, 9943–9950. [Google Scholar] [CrossRef] [PubMed]
  75. Ali, D.; Alarifi, S.; Alkahtani, S.; AlKahtane, A.A.; Almalik, A. Cerium Oxide Nanoparticles Induce Oxidative Stress and Genotoxicity in Human Skin Melanoma Cells. Cell Biochem. Biophys. 2015, 71, 1643–1651. [Google Scholar] [CrossRef] [PubMed]
  76. Alili, L.; Sack, M.; Karakoti, A.S.; Teuber, S.; Puschmann, K.; Hirst, S.M.; Reilly, C.M.; Zanger, K.; Stahl, W.; Das, S.; et al. Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor-stroma interactions. Biomaterials 2011, 32, 2918–2929. [Google Scholar] [CrossRef] [PubMed]
  77. Ristow, M. Oxidative metabolism in cancer growth. Curr. Opin. Clin. Nutr. Metab. Care 2006, 9, 339–345. [Google Scholar] [CrossRef]
  78. Singh, S.; Kumar, U.; Gittess, D.; Sakthivel, T.S.; Babu, B.; Seal, S. Cerium oxide nanomaterial with dual antioxidative scavenging potential: Synthesis and characterization. J. Biomater. Appl. 2021, 36, 834–842. [Google Scholar] [CrossRef]
  79. Celardo, I.; Traversa, E.; Ghibelli, L. Cerium oxide nanoparticles: A promise for applications in therapy. J. Exp. Ther. Oncol. 2011, 9, 47–51. [Google Scholar]
  80. Kunwar, D.; Zhou, S.; DeLaRiva, A.; Peterson, E.J.; Xiong, H.; Pereira-Hernández, X.I.; Purdy, S.C.; ter Veen, R.; Brongersma, H.H.; Miller, J.T.; et al. Stabilizing High Metal Loadings of Thermally Stable Platinum Single Atoms on an Industrial Catalyst Support. ACS Catal. 2019, 9, 3978–3990. [Google Scholar] [CrossRef]
  81. Pastor-Pérez, L.; Patel, V.; Le Saché, E.; Reina, T.R. CO2 methanation in the presence of methane: Catalysts design and effect of methane concentration in the reaction mixture. J. Energy Inst. 2020, 93, 415–424. [Google Scholar] [CrossRef]
  82. Ding, Y.; Wu, Q.; Lin, B.; Guo, Y.; Guo, Y.; Wang, Y.; Wang, L.; Zhan, W. Superior catalytic activity of a Pd catalyst in methane combustion by fine-tuning the phase of ceria-zirconia support. Appl. Catal. B Environ. 2020, 266, 118631. [Google Scholar] [CrossRef]
  83. Maria Magdalane, C.; Kaviyarasu, K.; Matinise, N.; Mayedwa, N.; Mongwaketsi, N.; Letsholathebe, D.; Mola, G.T.; AbdullahAl-Dhabi, N.; Arasu, M.V.; Henini, M.; et al. Evaluation on La2O3 garlanded ceria heterostructured binary metal oxide nanoplates for UV/visible light induced removal of organic dye from urban wastewater. S. Afr. J. Chem. Eng. 2018, 26, 49–60. [Google Scholar] [CrossRef]
  84. Jones, J.; Xiong, H.; DeLaRiva, A.T.; Peterson, E.J.; Pham, H.; Challa, S.R.; Qi, G.; Oh, S.; Wiebenga, M.H.; Pereira Hernández, X.I.; et al. Thermally stable single-atom platinum-on-ceria catalysts via atom trapping. Science 2016, 353, 150–154. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Das, S.; Ashok, J.; Bian, Z.; Dewangan, N.; Wai, M.H.; Du, Y.; Borgna, A.; Hidajat, K.; Kawi, S. Silica–Ceria sandwiched Ni core–shell catalyst for low temperature dry reforming of biogas: Coke resistance and mechanistic insights. Appl. Catal. B Environ. 2018, 230, 220–236. [Google Scholar] [CrossRef]
  86. Liu, Q.; Yang, Y.; Lv, X.; Ding, Y.; Zhang, Y.; Jing, J.; Xu, C. One-step synthesis of uniform nanoparticles of porphyrin functionalized ceria with promising peroxidase mimetics for H2O2 and glucose colorimetric detection. Sens. Actuators B Chem. 2017, 240, 726–734. [Google Scholar] [CrossRef]
  87. Sun, L.; Ding, Y.; Jiang, Y.; Liu, Q. Montmorillonite-loaded ceria nanocomposites with superior peroxidase-like activity for rapid colorimetric detection of H2O2. Sens. Actuators B Chem. 2017, 239, 848–856. [Google Scholar] [CrossRef]
  88. Atif, M.; Iqbal, S.; Fakhar-E-Alam, M.; Ismail, M.; Mansoor, Q.; Mughal, L.; Aziz, M.H.; Hanif, A.; Farooq, W.A. Manganese-Doped Cerium Oxide Nanocomposite Induced Photodynamic Therapy in MCF-7 Cancer Cells and Antibacterial Activity. BioMed Res. Int. 2019, 2019, 7156828. [Google Scholar] [CrossRef] [Green Version]
  89. Pelletier, D.A.; Suresh, A.K.; Holton, G.A.; McKeown, C.K.; Wang, W.; Gu, B.; Mortensen, N.P.; Allison, D.P.; Joy, D.C.; Allison, M.R.; et al. Effects of Engineered Cerium Oxide Nanoparticles on Bacterial Growth and Viability. Appl. Environ. Microbiol. 2010, 76, 7981–7989. [Google Scholar] [CrossRef] [Green Version]
  90. Yu, H.; Jin, F.; Liu, D.; Shu, G.; Wang, X.; Qi, J.; Sun, M.; Yang, P.; Jiang, S.; Ying, X.; et al. ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury. Theranostics 2020, 10, 2342–2357. [Google Scholar] [CrossRef]
  91. He, L.; Huang, G.; Liu, H.; Sang, C.; Liu, X.; Chen, T. Highly bioactive zeolitic imidazolate framework-8–capped nanotherapeutics for efficient reversal of reperfusion-induced injury in ischemic stroke. Sci. Adv. 2020, 6, eaay9751. [Google Scholar] [CrossRef] [Green Version]
  92. Kwon, H.J.; Cha, M.-Y.; Kim, D.; Kim, D.K.; Soh, M.; Shin, K.; Hyeon, T.; Mook-Jung, I. Mitochondria-Targeting Ceria Nanoparticles as Antioxidants for Alzheimer’s Disease. ACS Nano 2016, 10, 2860–2870. [Google Scholar] [CrossRef]
  93. Aksnes, D.W.; Langfeldt, L.; Wouters, P. Citations, Citation Indicators, and Research Quality: An Overview of Basic Concepts and Theories. SAGE Open 2019, 9, 2158244019829575. [Google Scholar] [CrossRef]
  94. Ebrahimi, P.; Kumar, A.; Khraisheh, M. A review of recent advances in water-gas shift catalysis for hydrogen production. Emergent Mater. 2020, 3, 881–917. [Google Scholar] [CrossRef]
  95. Crabtree, G.W.; Dresselhaus, M.S. The Hydrogen Fuel Alternative. MRS Bull. 2008, 33, 421–428. [Google Scholar] [CrossRef] [Green Version]
  96. Nyoka, M.; Choonara, Y.E.; Kumar, P.; Kondiah, P.P.D.; Pillay, V. Synthesis of Cerium Oxide Nanoparticles Using Various Methods: Implications for Biomedical Applications. Nanomaterials 2020, 10, 242. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  97. Li, M.; Liu, Z.; Hu, Y.; Wang, M.; Li, H. Effect of doping elements on catalytic performance of CeO2-ZrO2 solid solutions. J. Rare Earths 2008, 26, 357–361. [Google Scholar] [CrossRef]
  98. Mousavi-Kamazani, M.; Azizi, F. Facile sonochemical synthesis of Cu doped CeO2 nanostructures as a novel dual-functional photocatalytic adsorbent. Ultrason. Sonochem. 2019, 58, 104695. [Google Scholar] [CrossRef] [PubMed]
  99. Mužina, K.; Kurajica, S.; Dražić, G.; Guggenberger, P.; Matijašić, G. True doping levels in hydrothermally derived copper-doped ceria. J. Nanopart. Res. 2021, 23, 149. [Google Scholar] [CrossRef]
  100. Sharma, P.K.; Pandey, O.P. Enhanced photocatalytic activity with metal ion doping and co-doping in CeO2 nanoparticles. Solid State Sci. 2022, 126, 106846. [Google Scholar] [CrossRef]
  101. Walkey, C.; Das, S.; Seal, S.; Erlichman, J.; Heckman, K.; Ghibelli, L.; Traversa, E.; McGinnis, J.F.; Self, W.T. Catalytic Properties and Biomedical Applications of Cerium Oxide Nanoparticles. Environ. Sci. Nano 2015, 2, 33–53. [Google Scholar] [CrossRef] [Green Version]
  102. Ighodaro, O.M.; Akinloye, O.A. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alex. J. Med. 2018, 54, 287–293. [Google Scholar] [CrossRef] [Green Version]
  103. Nourmohammadi, E.; Khoshdel-sarkarizi, H.; Nedaeinia, R.; Darroudi, M.; Kazemi Oskuee, R. Cerium oxide nanoparticles: A promising tool for the treatment of fibrosarcoma in-vivo. Mater. Sci. Eng. C 2020, 109, 110533. [Google Scholar] [CrossRef] [PubMed]
  104. Alpaslan, E.; Yazici, H.; Golshan, N.; Ziemer, K.; Webster, T. Dextran coated cerium oxide nanoparticles for inhibiting bone cancer cell functions. Biomater. Sci. Process. Prop. Appl. V 2015, 254, 187–196. [Google Scholar]
  105. Valdeperez, D.; Wang, T.; Eußner, J.P.; Weinert, B.; Hao, J.; Parak, W.J.; Dehnen, S.; Pelaz, B. Polymer-coated nanoparticles: Carrier platforms for hydrophobic water- and air-sensitive metallo-organic compounds. Pharmacol. Res. 2017, 117, 261–266. [Google Scholar] [CrossRef] [PubMed]
  106. Bagheri, S.; Khalil, M.; Muhd Julkapli, N. Cerium (IV) oxide nanocomposites: Catalytic properties and industrial application. J. Rare Earth. 2020, 39, 129–139. [Google Scholar] [CrossRef]
  107. Fu, Q.; Deng, W.; Saltsburg, H.; Flytzani-Stephanopoulos, M. Activity and stability of low-content gold–cerium oxide catalysts for the water–gas shift reaction. Appl. Catal. B Environ. 2005, 56, 57–68. [Google Scholar] [CrossRef]
  108. Alpaslan, E.; Yazici, H.; Golshan, N.H.; Ziemer, K.S.; Webster, T.J. pH-Dependent Activity of Dextran-Coated Cerium Oxide Nanoparticles on Prohibiting Osteosarcoma Cell Proliferation. ACS Biomater. Sci. Eng. 2015, 1, 1096–1103. [Google Scholar] [CrossRef]
  109. Datta, A.; Mishra, S.; Manna, K.; Saha, K.D.; Mukherjee, S.; Roy, S. Pro-Oxidant Therapeutic Activities of Cerium Oxide Nanoparticles in Colorectal Carcinoma Cells. ACS Omega 2020, 5, 9714–9723. [Google Scholar] [CrossRef] [Green Version]
  110. Alpaslan, E.; Geilich, B.M.; Yazici, H.; Webster, T.J. pH-Controlled Cerium Oxide Nanoparticle Inhibition of Both Gram-Positive and Gram-Negative Bacteria Growth. Sci. Rep. 2017, 7, 45859. [Google Scholar] [CrossRef] [Green Version]
  111. Chelombitko, M.A. Role of Reactive Oxygen Species in Inflammation: A Minireview. Mosc. Univ. Biol. Sci. Bull. 2018, 73, 199–202. [Google Scholar] [CrossRef] [Green Version]
  112. Dewberry, L.K.; Zgheib, C.; Hilton, S.A.; Seal, S.; Newsom, J.; Krebs, M.D.; Hu, J.; Xu, J.; Liechty, K.W. Cerium Oxide Nanoparticle-miR146a Decreases Inflammation in a Murine Dextran Sodium Sulfate Colitis Model. J. Am. Coll. Surg. 2019, 229, S91. [Google Scholar] [CrossRef]
  113. Chai, W.F.; Tang, K.S. Protective potential of cerium oxide nanoparticles in diabetes mellitus. J. Trace Elem. Med. Biol. 2021, 66, 126742. [Google Scholar] [CrossRef]
  114. Wei, F.; Neal, C.J.; Sakthivel, T.S.; Kean, T.; Seal, S.; Coathup, M.J. Multi-functional cerium oxide nanoparticles regulate inflammation and enhance osteogenesis. Mater. Sci. Eng. C 2021, 124, 112041. [Google Scholar] [CrossRef] [PubMed]
  115. Jan, A.; Shin, J.; Ahn, J.; Yang, S.; Yoon, K.J.; Son, J.-W.; Kim, H.; Lee, J.-H.; Ji, H.-I. Promotion of Pt/CeO2 catalyst by hydrogen treatment for low-temperature CO oxidation. RSC Adv. 2019, 9, 27002–27012. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  116. Muravev, V.; Spezzati, G.; Su, Y.-Q.; Parastaev, A.; Chiang, F.-K.; Longo, A.; Escudero, C.; Kosinov, N.; Hensen, E.J.M. Interface dynamics of Pd–CeO2 single-atom catalysts during CO oxidation. Nat. Catal. 2021, 4, 469–478. [Google Scholar] [CrossRef]
  117. Sack, Z.; Bader, S.; Brenneisen, P. Cerium Oxide Nanoparticles as Novel Tool in Glioma Treatment: An In vitro Study. J. Nanomed. Nanotechnol. 2017, 8, 1–9. [Google Scholar] [CrossRef] [Green Version]
  118. Naz, S.; Beach, J.; Heckert, B.; Tummala, T.; Pashchenko, O.; Banerjee, T.; Santra, S. Cerium oxide nanoparticles: A ‘radical’ approach to neurodegenerative disease treatment. Nanomedicine 2017, 12, 545–553. [Google Scholar] [CrossRef] [Green Version]
  119. Gunawan, C.; Lord, M.S.; Lovell, E.; Wong, R.J.; Jung, M.S.; Oscar, D.; Mann, R.; Amal, R. Oxygen-Vacancy Engineering of Cerium-Oxide Nanoparticles for Antioxidant Activity. ACS Omega 2019, 4, 9473–9479. [Google Scholar] [CrossRef]
  120. Gella, A.; Durany, N. Oxidative stress in Alzheimer disease. Cell Adhes. Migr. 2009, 3, 88–93. [Google Scholar] [CrossRef] [Green Version]
  121. Heneka, M.T.; Carson, M.J.; El Khoury, J.; Landreth, G.E.; Brosseron, F.; Feinstein, D.L.; Jacobs, A.H.; Wyss-Coray, T.; Vitorica, J.; Ransohoff, R.M. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015, 14, 388–405. [Google Scholar] [CrossRef] [Green Version]
  122. D’Angelo, B.; Santucci, S.; Benedetti, E.; Di Loreto, S.; Phani, A.; Falone, S.; Amicarelli, F.; Cerù, M.; Cimini, A. Cerium Oxide Nanoparticles Trigger Neuronal Survival in a Human Alzheimer Disease Model By Modulating BDNF Pathway. Curr. Nanosci. 2009, 5, 167–176. [Google Scholar] [CrossRef]
  123. Siposova, K.; Huntosova, V.; Shlapa, Y.; Lenkavska, L.; Macajova, M.; Belous, A.; Musatov, A. Advances in the Study of Cerium Oxide Nanoparticles: New Insights into Antiamyloidogenic Activity. ACS Appl. Bio Mater. 2019, 2, 1884–1896. [Google Scholar] [CrossRef] [PubMed]
  124. Kumari, M.; Singh, S.P.; Chinde, S.; Rahman, M.F.; Mahboob, M.; Grover, P. Toxicity Study of Cerium Oxide Nanoparticles in Human Neuroblastoma Cells. Int. J. Toxicol. 2014, 33, 86–97. [Google Scholar] [CrossRef] [PubMed]
  125. Lin, W.; Huang, Y.-W.; Zhou, X.-D.; Ma, Y. Toxicity of Cerium Oxide Nanoparticles in Human Lung Cancer Cells. Int. J. Toxicol. 2006, 25, 451–457. [Google Scholar] [CrossRef] [PubMed]
  126. Niu, J.; Azfer, A.; Rogers, L.M.; Wang, X.; Kolattukudy, P.E. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc. Res. 2007, 73, 549–559. [Google Scholar] [CrossRef]
Ijms 24 02048 g001 550
Figure 1. The top 19 topic models formulated from the dataset collected from PubMed (129 publications) with the SWIFT-Review software, using the search term “cerium oxide OR ceria OR nanoceria OR nano ceria”. This search was refined to review, clinical trials, meta-analysis, and research articles. Accessed on the 17 September 2020.
Figure 1. The top 19 topic models formulated from the dataset collected from PubMed (129 publications) with the SWIFT-Review software, using the search term “cerium oxide OR ceria OR nanoceria OR nano ceria”. This search was refined to review, clinical trials, meta-analysis, and research articles. Accessed on the 17 September 2020.
Ijms 24 02048 g001
Ijms 24 02048 g002 550
Figure 2. Network visualization map showing nine color-coded clusters produced using the VOSviewer and the WoS Database with the search “cerium oxide OR ceria OR nanoceria OR nano ceria”. The network analysis from 7862 publications and 144 author key words, from 1990 to 2020. The colours represent the clusters of keywords presented in Table 3. Access on the 17 September 2020.
Figure 2. Network visualization map showing nine color-coded clusters produced using the VOSviewer and the WoS Database with the search “cerium oxide OR ceria OR nanoceria OR nano ceria”. The network analysis from 7862 publications and 144 author key words, from 1990 to 2020. The colours represent the clusters of keywords presented in Table 3. Access on the 17 September 2020.
Ijms 24 02048 g002
Ijms 24 02048 g003 550
Figure 3. Main themes in the cerium oxide related publications from the Scopus database, over four time periods identified using SciMAT software (a) 1990–1997 (n = 1047); (b) 1998–2005 (n = 2937); (c) 2006–2013 (n = 7858); (d) 2014–2020 (n = 5273). The figure demonstrates the development of cerium oxide investigation and the links in terms of the major themes, identified for each period. Accessed on the 9 October 2020.
Figure 3. Main themes in the cerium oxide related publications from the Scopus database, over four time periods identified using SciMAT software (a) 1990–1997 (n = 1047); (b) 1998–2005 (n = 2937); (c) 2006–2013 (n = 7858); (d) 2014–2020 (n = 5273). The figure demonstrates the development of cerium oxide investigation and the links in terms of the major themes, identified for each period. Accessed on the 9 October 2020.
Ijms 24 02048 g003
Ijms 24 02048 g004 550
Figure 4. Frequency histogram of 172 publications, derived from a systematic search of cerium oxide literature, conducted in the Scopus database for search terms: “cerium oxide OR ceria OR nanoceria OR nano ceria” AND doping-additives/catalysts/reactive oxygen species/pathology, showing the surge of publication activity across all four themes between 2019–2020. The year of 2020 demonstrating the highest number of publications. Accessed on 17 September 2020.
Figure 4. Frequency histogram of 172 publications, derived from a systematic search of cerium oxide literature, conducted in the Scopus database for search terms: “cerium oxide OR ceria OR nanoceria OR nano ceria” AND doping-additives/catalysts/reactive oxygen species/pathology, showing the surge of publication activity across all four themes between 2019–2020. The year of 2020 demonstrating the highest number of publications. Accessed on 17 September 2020.
Ijms 24 02048 g004
Ijms 24 02048 g005 550
Figure 5. Top 11 countries, with the highest citations (minimum 10) and documents (minimum 10) per authors, grouped by country affiliations. Extrapolated from the dataset obtained from the WoS database, using the term “cerium oxide or ceria or nanoceria or nano ceria” in the years 1990–2020. Accessed on the 9 October 2020.
Figure 5. Top 11 countries, with the highest citations (minimum 10) and documents (minimum 10) per authors, grouped by country affiliations. Extrapolated from the dataset obtained from the WoS database, using the term “cerium oxide or ceria or nanoceria or nano ceria” in the years 1990–2020. Accessed on the 9 October 2020.
Ijms 24 02048 g005
Ijms 24 02048 g006 550
Figure 6. Graphical depiction of the various biomedical applications of cerium oxide nanoparticles as therapies for a wide range of pathologies including cancer, diabetes, cardiovascular pulmonary disease, macular degeneration, ischemic stroke and bacterial infection due to the bifunctional nature of CeO2. In acidic conditions the antioxidant ability of CeONPs is lost, behaving instead much like a strong oxidant, which may influence the oxidation of intracellular and extracellular components to induce apoptosis. This ability to become cytotoxic has been found to induce oxidative stress, could be attributed to cancer cells being more acidic than normal cells.
Figure 6. Graphical depiction of the various biomedical applications of cerium oxide nanoparticles as therapies for a wide range of pathologies including cancer, diabetes, cardiovascular pulmonary disease, macular degeneration, ischemic stroke and bacterial infection due to the bifunctional nature of CeO2. In acidic conditions the antioxidant ability of CeONPs is lost, behaving instead much like a strong oxidant, which may influence the oxidation of intracellular and extracellular components to induce apoptosis. This ability to become cytotoxic has been found to induce oxidative stress, could be attributed to cancer cells being more acidic than normal cells.
Ijms 24 02048 g006
Ijms 24 02048 g007 550
Figure 7. (A) Graphical representation of the various nanoparticle engineering manipula-tions of cerium oxide that have been implemented in (B) various biomedical applications (e.g., drug delivery agent, diagnosis, anti-cancer agent and contrasting agent).4. Materials and Methods.
Figure 7. (A) Graphical representation of the various nanoparticle engineering manipula-tions of cerium oxide that have been implemented in (B) various biomedical applications (e.g., drug delivery agent, diagnosis, anti-cancer agent and contrasting agent).4. Materials and Methods.
Ijms 24 02048 g007
Ijms 24 02048 g008 550
Figure 8. Graphical depiction of the systemic literature review process of the WoS database (numbers represent the number of publications analysed at that step).
Figure 8. Graphical depiction of the systemic literature review process of the WoS database (numbers represent the number of publications analysed at that step).
Ijms 24 02048 g008
Table
Table 1. Summary of the number of papers identified in searchers of different databases (PubMed, WoS and Scopus) using the search terms “cerium oxide OR ceria OR nanoceria OR nano ceria” from the years 1990–2020.
Table 1. Summary of the number of papers identified in searchers of different databases (PubMed, WoS and Scopus) using the search terms “cerium oxide OR ceria OR nanoceria OR nano ceria” from the years 1990–2020.
Search TermsPubMedWoSScopus
Cerium oxide12227,67422,467
Cerium oxide and nanoparticles5916,252738
Cerium oxide and pathology1713,350193
Cerium oxide and toxicity2914,533624
Notes: Accessed on the 17 December 2020, and covered the article, title, abstract, and keywords.
Table
Table 2. Top 19 topic models generated from PubMed dataset (129 publications) by SWIFT-Review software using the search terms “cerium oxide OR ceria OR nanoceria OR nano ceria”. This search was refined to review, clinical trials, meta-analysis, and research articles. The topics have been ordered by number of publications contributing to the topic model in descending order, with topic words and themes established.
Table 2. Top 19 topic models generated from PubMed dataset (129 publications) by SWIFT-Review software using the search terms “cerium oxide OR ceria OR nanoceria OR nano ceria”. This search was refined to review, clinical trials, meta-analysis, and research articles. The topics have been ordered by number of publications contributing to the topic model in descending order, with topic words and themes established.
Topic No.Topic WordNo. of Publications
in Topic Model		Brief Description of
Topic
34Applications, properties, synthesis, review, biomedical, advances101Properties for biomedical applications
97Nanoparticles, oxide, cerium, review, activity, properties, oxidative, research85Oxidative Properties
8Ceria, materials, surface, application, energy, properties, systems, structure, material57Surface materials and structure
84Current literature, include, increase, therapies, existing conditions49Therapies
5Antioxidant, potential, species, effects vivo reactive, stress, biological, ROS, oxygen46Antioxidant properties
1Therapy, clinical outcomes, patients, improved, scientific approaches38Clinical approaches
93Catalysts, catalytic, reactions, oxidation, reaction, ceria-based, catalyst, high activity, organic28Catalytic properties
18Medicine, role, toxicity, regenerative, promising, industry, recent26Medicinal therapies
21HIV, trial, study, incarcerated, months, release, randomized, results, observed treatment23Randomized trials
51Challenges, cells, order, progress, systems, target, addition, improve, medical barriers23Targeted treatments
28Model, studies, hydrogen, techniques, design, kinetics, water-gas, knowledge, modelling, advanced21Kinetic studies
70CEONPs, surface, oxygen, vacancies, lattice, results, experimental, presence, evidence20Surface structure
86Nanoceria, cells, CEONPs, particles, anti-cancer, data, point, improve, agent normal19Anti-cancer agent
48Design, role, aims, emissions, reviews, interest, carbon, focusing, develop, materials18Carbon emission materials
69Health, effects, exposure, fuel, engineered, risk, toxicological, studies, air18Air pollution
72Synthesis, methods, synthetic, number, template, products, implications, function, metals, enhanced18Synthesis methods
38Treatment, development, growth, pathway, inhibitors, target, tumour, kinase, receptor, phase17Tumour kinase pathway
63Review, systematic, studies, outcomes, articles, results, reported, included published, gaps17Systematic reviews
85Control, research, populations, article, needed, major, practice, describes, provided, discussion, gaps16Research gaps
Notes: Accessed on the 17 September 2020. Refined to review, clinical trials, meta-analysis, and research articles.
Table
Table 3. Summary of the word clusters identified using VOSviewer and WoS dataset using the search term “cerium oxide OR ceria OR nanoceria OR nano ceria”. The network analysis from 7862 publications from 1990 to 2020. The clusters are also represented in a visualisation map (Figure 2).
Table 3. Summary of the word clusters identified using VOSviewer and WoS dataset using the search term “cerium oxide OR ceria OR nanoceria OR nano ceria”. The network analysis from 7862 publications from 1990 to 2020. The clusters are also represented in a visualisation map (Figure 2).
ClusterLay/DescriptionKeywords
1Biocompatibility as a biomedical applicationAntioxidant, apoptosis, biocompatibility, blood-brain-barrier, catalase, cerium oxide nanoparticles, cytotoxicity, drug delivery, genotoxicity, inflammation, nanoceria, nanomedicine, nanotechnology, oxidative stress, translocation
2Surface coating additivesCatalyst, cerium oxide, cobalt oxide, copper, hydrogen production, hydrogen peroxide, hydrogen production, interface, methane, nickel, oxygen reduction reaction
3Catalytic properties remediationBiodiesel, catalytic oxidation, cathode, ceria nanoparticles, conductivity, electrolyte, manganese oxide, metal oxides, methanol, palladium, reaction mechanism, stability
4Manufacturing alterationsCatalysis, ceramics, coatings, copper oxide, crystal structure, defects, doping, nanostructures, optical properties, oxides, photocatalytic activity, ramen spectroscopy, solid solution, structure
5Advancements in thermal
stability		Adsorption, antibacterial activity, co-precipitation, coating, corrosion, resistance, electron microscopy, hydrothermal synthesis, kinetics, mechanical properties, metal oxide, microstructure, thermal stability, X-ray diffraction
6Advancements in manufacturing (nanocomposites) improved efficiencyCorrosion, electrochemical sensors, electrodeposition, ionic conductivity, lanthanum oxide, mechanism, nanocomposite, oxygen vacancies, photocatalysis, rare earth metals, reduced graphene oxide, thin film, titanium dioxide, zinc oxide
7Degradation, air pollutant and biomedical applicantCatalytic ozonation, cerium dioxide, degradation, graphene oxide, inhalation, nanomaterial, nanozyme, wound healing
8Catalytic interaction of doped cerium oxideDoped ceria, heterogenous catalysis, metal-support interaction, oxygen vacancy, sintering, synergistic effect
9Antioxidant activityAggregation, anti-bacterial, antioxidant activity, morphology, ROS, silver nanoparticles, toxicity
Note: Accessed on the 17 September 2020.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Fleming, C.L.; Wong, J.; Golzan, M.; Gunawan, C.; McGrath, K.C. Insights from a Bibliometrics-Based Analysis of Publishing and Research Trends on Cerium Oxide from 1990 to 2020. Int. J. Mol. Sci. 2023, 24, 2048. https://doi.org/10.3390/ijms24032048

AMA Style

Fleming CL, Wong J, Golzan M, Gunawan C, McGrath KC. Insights from a Bibliometrics-Based Analysis of Publishing and Research Trends on Cerium Oxide from 1990 to 2020. International Journal of Molecular Sciences. 2023; 24(3):2048. https://doi.org/10.3390/ijms24032048

Chicago/Turabian Style

Fleming, Charlotte L., Jessie Wong, Mojtaba Golzan, Cindy Gunawan, and Kristine C. McGrath. 2023. "Insights from a Bibliometrics-Based Analysis of Publishing and Research Trends on Cerium Oxide from 1990 to 2020" International Journal of Molecular Sciences 24, no. 3: 2048. https://doi.org/10.3390/ijms24032048

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop